METABOLISM AND CHIRALITY IN PSYCHOPHARMACOLOGY - INTRODUCTION

被引：6

作者：

BAKER, GB

COUTTS, RT

HOLT, A

机构：

来源：

BIOLOGICAL PSYCHIATRY | 1994年 / 36卷 / 04期

关键词：

D O I：

10.1016/0006-3223(94)90601-7

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

收藏

页码：211 / 213

页数：3

相关论文

共 32 条

[1] METABOLISM OF MONOAMINE-OXIDASE INHIBITORS
BAKER, GB
COUTTS, RT
[J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1989, 13 (3-4) : 395 - 403
[2] CLINICAL PHARMACOKINETICS OF CITALOPRAM AND OTHER SELECTIVE SEROTONERGIC REUPTAKE INHIBITORS (SSRI)
BAUMANN, P
[J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 6 : 13 - 20
[3] QUANTIFICATION AND MECHANISM OF THE FLUOXETINE AND TRICYCLIC ANTIDEPRESSANT INTERACTION
BERGSTROM, RF
PEYTON, AL
LEMBERGER, L
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (03) : 239 - 248
[4] FLUOXETINE AND NORFLUOXETINE ARE POTENT INHIBITORS OF P450IID6 - THE SOURCE OF THE SPARTEINE DEBRISOQUINE OXIDATION POLYMORPHISM
BROSEN, K
SKJELBO, E
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (01) : 136 - 137
[5] RECENT DEVELOPMENTS IN HEPATIC DRUG OXIDATION - IMPLICATIONS FOR CLINICAL PHARMACOKINETICS
BROSEN, K
[J]. CLINICAL PHARMACOKINETICS, 1990, 18 (03) : 220 - 239
[6] CIRAULO DA, 1990, J CLIN PSYCHOPHARM, V10, P213
[7] FLUOXETINE DRUG-DRUG INTERACTIONS .1. ANTIDEPRESSANTS AND ANTIPSYCHOTICS
CIRAULO, DA
SHADER, RI
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1990, 10 (01) : 48 - 50
[8] MONOAMINE OXIDASE CATALYZED DEGRADATION OF PHENELZINE-1-14C AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE .2.
CLINESCHMIDT, BV
HORITA, A
[J]. BIOCHEMICAL PHARMACOLOGY, 1969, 18 (05) : 1021 - +
[9] IMPLICATIONS OF CHIRALITY AND GEOMETRIC ISOMERISM IN SOME PSYCHOACTIVE-DRUGS AND THEIR METABOLITES
COUTTS, RT
BAKER, GB
[J]. CHIRALITY, 1989, 1 (02) : 99 - 120
[10] COUTTS RT, 1994, J PSYCHIATR NEUROSCI, V19, P30

← 1 2 3 4 →